繁體
简体中文
繁體中文

Ardelyx ARDX

等待開盤 08-28 09:30:00 美东时间

6.15

-0.050

-0.81%

华盛通華盛通
立即下載
  • 最 高6.26
  • 今 開6.15
  • 成交量 156.29万股
  • 最 低 6.11
  • 昨 收 6.20
  • 總市值 14.70亿
  • 52周最高 7.18
  • 市盈率 --
  • 換手率 0.65%
  • 52周最低 3.21
  • 委 比 -39.90%
  • 總股本 2.39亿
  • 歷史最高 35.48
  • 量 比 0.59
  • 振 幅 2.42%
  • 歷史最低 0.49
  • 每 手 1
  • 風險率 0.83%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Ardelyx to Participate in Upcoming Investor Conferences

    Ardelyx, Inc. announced its participation in four upcoming investor conferences in September 2025. The events include the Citi Biopharma Back to School Summit in Boston, and three conferences in New York: Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and H.C. Wainwright Global Investment Conference. Ardelyx will host Fireside Chats and 1x1 meetings at each event. Additionally, Ardelyx has two commercial product...

    08-25 12:00

  • Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $14

    Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $13 to $14.

    08-05 23:28

  • Here are the major earnings after the close Monday

    Major earnings expected after the bell on Monday include: Palantir Technologies (PLTR) Simon Property Group (SPG) MercadoLibre (MELI) ONEOK (OKE) Vertex Pharmaceuticals Incorporated (VRTX) Other earni...

    08-04 22:00

  • Ardelyx Announces Changes to the Executive Leadership Team

    <p>Ardelyx, Inc. announced leadership changes, appointing Edward Conner, M.D. as Chief Medical Officer and John Bishop, Ph.D. as Chief Technical Operations Officer. Justin Renz, Chief Financial and Operations Officer, will transition out of the Company later this year. The company emphasized its commitment to growth and achieving its mission of creating innovative medicines to meet unmet medical needs.</p>

    08-04 20:08

  • Earnings Scheduled For August 4, 2025

    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...

    08-04 16:32

  • What to Expect from Ardelyx's Earnings

    Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...

    08-02 04:01

  • Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

    Ardelyx, Inc. will hold a conference call on August 4, 2025, at 4:30 p.m. Eastern Time to discuss second-quarter 2025 financial results and provide a business update. Participants can join by dialing (877) 346-6112 (domestic) or (848) 280-6350 (international) and asking to join the Ardelyx call. The call will also be webcast live and archived on the company’s website for 30 days. Ardelyx is a biopharmaceutical company focused on developing first-...

    07-21 12:00

  • Ardelyx Secures $50 Million Loan Amendment

    Ardelyx ( ($ARDX) ) has provided an announcement. On June 30, 2025, Ardelyx, In...

    07-03 21:18

  • Ardelyx spike attributed to Xphozah legal update

    Ardelyx (NASDAQ:ARDX) shares rose ~9% on Wednesday, a move Jefferies attributed to a major update related to the company's ongoing legal battle with the U.S. government over Medicare coverage for its ...

    07-03 01:38

  • 美股大行评级 | 潜在涨幅261.01%!瑞穗上调Immuneering目标价至10美元,维持"跑赢大市"评级

    康托·菲茨杰拉德:维持Meta Platforms(META)"超配"评级,目标价从676美元升至807美元

    06-19 09:23